Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma

doi:10.5306/wjco.v8.i6.429

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9739)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

734

WORD

320

HTML

5445

Figures (1-3)

252

Tables (1-1)

228

Sum=6979

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1207

Download

1553

Sum=2760

Dec 10, 2017 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (64)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Dec 10, 2017; 8(6): 429-436
Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.429

Full Size Figure Download Figure

Figure 3 Barcelona clinic liver cancer staging system[36]. HCC: Hepatocellular carcinoma; TACE: Trans-arterial chemoembolization.

Citation: Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol 2017; 8(6): 429-436
URL: https://www.wjgnet.com/2218-4333/full/v8/i6/429.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i6.429